Trials / Sponsors / Dai, Guanghai
Dai, Guanghai
Academic / Other · 5 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Seco Gastric Cancer Adenocarcinoma Metastatic | Phase 2 | 2025-12-01 |
| Recruiting | Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS Colorectal Cancer Metastatic | Phase 2 | 2024-08-16 |
| Recruiting | Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Re Advanced Biliary Tract Cancer | Phase 2 | 2024-08-15 |
| Recruiting | Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV Advanced Pancreatic Cancer (Part 1) | Phase 1 / Phase 2 | 2024-06-23 |
| Unknown | Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer Advanced Biliary Tract Cancer | Phase 2 | 2019-05-01 |